BioSpace News Archive

Oral presentation on the results of sintilimab for relapsed/refractory extranodal NK/T cell lymphoma

Aeneas Capital Limited and Pyrinas Real Estate Management Limited, based in Hong Kong, is launching a US$120m innovative closed-ended property fund – Pyrinas US Healthcare Real Estate Fund 1 SP – with a geographical focus on selected cities across North America.

Tizona Therapeutics, Inc., a privately held immunotherapy company, today announced the appointment of Daniel K. Spiegelman to its Board of Directors.

ProBioGen AG, a premier German service & technology provider for complex biologics and Vaccitech, Ltd., a spin-out company from the University of Oxford’s Jenner Institute, one of the most renowned vaccine research centers in the world, today jointly announced signing a license agreement

Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH) today announced its revenues and cash position for the first three-months of 2019.

Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, announced today that the Scleroderma: Cyclophosphamide or Transplantation (SCOT) trial is the recipient of the prestigious David Sackett Trial of the Year Award, presented annually by the Society for Clinical Trials (SCT)

Actuate Therapeutics, Inc., a clinical stage biopharmaceutical company, today announced it has raised $21.7 Million in a Series B financing round.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Venclexta® (venetoclax) in combination with Gazyva® (obinutuzumab) for the treatment of people with previously untreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).

Enhances patient education processes, streamlines workflows

Oppenheimer & Co. Inc. – a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings – will host its New York Oncology Insight Summit at The Barclay Intercontinental Hotel in New York City on May 16, 2019.